1. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm. 2006; 2. 113(2):239–254. PMID:
15959848.
Article
2. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993; 9. 90(17):7915–7922. PMID:
8367443.
Article
3. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev. 2003; 2. 7(1):35–51. PMID:
12586529.
4. Sofic E, Rustembegovic A, Kroyer G, Cao G. Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm. 2002; 5. 109(5-6):711–719. PMID:
12111462.
Article
5. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003; 10. 124(4):1386–1392. PMID:
14555570.
Article
6. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002; 4. 165(7):934–939. PMID:
11934717.
Article
7. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000; 8. 162(2 Pt 1):566–570. PMID:
10934088.
8. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath. 2003; 9. 7(3):105–110. PMID:
14569521.
Article
9. Kontogianni K, Messini-Nikolaki N, Christou K, Gourgoulianis K, Tsilimigaki S, Piperakis SM. DNA damage and repair capacity in lymphocytes from obstructive sleep apnea patients. Environ Mol Mutagen. 2007; 12. 48(9):722–727. PMID:
17973309.
Article
10. Jordan W, Reinbacher A, Cohrs S, Grunewald RW, Mayer G, Ruther E, et al. Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides. 2005; 9. 26(9):1654–1660. PMID:
16112406.
Article
11. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J. 2000; 10. 16(4):644–647. PMID:
11106206.
Article
12. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004; 2. 27(1):123–128. PMID:
14998248.
13. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, Gokhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta. 2003; 6. 332(1-2):83–88. PMID:
12763284.
14. Muns G, Rubinstein I, Bergmann KC. Phagocytosis and oxidative burst of blood phagocytes in chronic obstructive airway disease. Scand J Infect Dis. 1995; 27(4):369–373. PMID:
8658072.
15. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J. 2005; 11. 26(22):2435–2439. PMID:
16105851.
Article
16. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 3. 175(1):184–191. PMID:
3345800.
Article
17. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl. 2000; 6. 742(2):315–325. PMID:
10901136.
Article
18. Wali SO, Bahammam AS, Massaeli H, Pierce GN, Iliskovic N, Singal PK, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep. 1998; 5. 21(3):290–296. PMID:
9595608.